Isolation and characterisation of radioresistant human KB carcinoma cells in vitro

Oral Oncology

Volumn 34, Issue 1, 1998, Pages 30-38

  Yanagisawa, T ^a   Urade, M ^a   Takahashi, Y ^a   Kishimoto, H ^a   Sakurai, K ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Cross resistance to anticancer drugs; Mutant p53 protein; Oral carcinoma cells; Radioresistance

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; METHYLNITRONITROSOGUANIDINE; MITOMYCIN C; MUTAGENIC AGENT; PROTEIN P53; VINCRISTINE SULFATE;

ARTICLE; CELL GROWTH; CELL ISOLATION; CELL STRAIN KB; CONTROLLED STUDY; CROSS RESISTANCE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 0031919887     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00048-1     Document Type: Article

References (23)

1. [1] Sinden RR, Cole RS. Repair of cross-linked DNA and survival of Escherichia coli treated with psoralen and light: effects of mutations influencing genetic recombination and DNA metabolism. Journal of Bacteriology 1978;136:538-547.
2. [2] Sargentini NJ, Smith KC. Quantitation of the involvement of the rec A, rec B, rec C, rec F, rec J, rec N, lex A, rad A, rad B, uvr D, and umu C genes in the repair of X-ray-induced DNA double-strand breaks in Escherichia coli. Radiation Research 1982;107: 58-72.
3. [3] Prakash S, Sung P, Prakash L. DNA repair genes and proteins of Saccharomyces cerevisiae. Annual Review of Genetics 1993;27:33-70.
4. [4] Kemp IM, Sedgwick SG, Jeggo PA. X-ray sensitive mutants of Chinese hamster ovary cells defective in double-strand break rejoining. Mutation Research 1984;132:189-196.
5. [5] Stackhouse MA, Bedford JS. An ionizing radiation-sensitive mutant of CHO cells: irs-20. Radiation Research 1993;136:241-249.
6. [6] Eagle H. Propagation in a fluid medium of human epidermoid carcinoma, strain KB. Proceedings of the Society for Experimental Biology and Medicine 1955;89:362-364.
7. [7] Kaltenbach JP, Kaltenbach MH, Lyons WB. Nigrosin as a dye for differentiating live and dead ascites cells. Experimental Cell Research 1958;15:112-117.
8. [8] Banks L, Matlashewski G, Crawford L. Isolation of human-p53-specific antibodies and their use in studies of human p53 expression. European Journal of Biochemistry 1986;159:529-534.
9. [9] Gannon JV, Greanes R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO Journal 1990;9:1595-1602.
10. [10] Gupta RS. Genetic, biological and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16-213. Cancer Research 1983;43:1568-1574.
11. [11] Weichselbaum RR, Beckett MA, Schwartz JL, Dritschilo A. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. International Journal of Radiation Oncology Biology Physics 1988;15:575-579.
12. [12] Crooijmans RP, Schwachofer JH, Hoogenhout J. The influence of pre-irradiation on the survival of two head and neck squamous cell carcinoma lines. Anticancer Research 1991;11:297-299.
13. [13] Pekkola-Heino K, Kulmala J, Grenman S, Carey TE, Grenman R. Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro. Cancer Research 1991;49:4876-4878.
14. [14] Grenman R, Carey TE, McClatchey KD, et al. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 1991;67:2741-2747.
15. [15] Cowan JM, Beckett MA, Weichselbaum RR. Chromosome changes characterizing in vitro response to radiation in human squamous cell carcinoma lines. Cancer Research 1993;53:5542-5547.
16. [16] Kasid U, Pfeifer A, Weichselbaum RR, Dritschilo A, Mark GE. The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science (Washington, D.C.) 1987;237:1039-1041.
17. [17] Chang EH, Pirollo KF, Zou ZQ, et al., Oncogenes in radio-resistant, noncancerous skin fibroblasts from a cancer-prone family. Science (Washington, D.C.), 1987;237:1036-1039.
18. [18] Sawey MJ, Hood AT, Burns FJ, Garte SJ. Activation of c-myc and c-K-ras oncogenes in primary rat tumors induced by ionizing radiation. Molecular and Cell Biology 1987;7:932-935.
19. [19] Jung M, Notario V, Dritschilo A. Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Cancer Research 1992;52:6390-6393.
20. [20] Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. p53 mutation does not correlate with radio-sensitivity in 24 head and neck cancer cell lines. Cancer Research 1993;53:3667-3669.
21. [21] Lee JM, Bernstein A. p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences USA 1993;90:5742-5746.
22. [22] Fan S, El-Deiry WS, Bae I, et al. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Research, 1994;54:5824-5830.
23. [23] Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991;6:1785-1789.